Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
New York State Workers’ Compensation Board Restores Previous Requirements
On November 23, 2022, the New York State Workers’ Compensation Board
Business Insurance
In the News
Sharp Drop in Opioid Prescriptions Raises Questions Over Other Drugs
mitchell
News Release
Aviva Canada Selects Mitchell Solutions to Help Streamline Claims Management
SAN DIEGO, Calif.— Mitchell, an Enlyte company and leading technology and information provider for the
Workers' Comp
White Paper
Unlocking the DME “Black Box”
Mitchell
News Release
CDC Updates and Replaces Guidelines for Prescribing Opioids
The Centers for Disease Control and Prevention (CDC) released an updated and expanded recommendation for clinicians prescribing opioids for outpati
PRIMA
Article
The Impact of Resilience on Recovery from Injury or Illness
Read now